Knights Of Columbus Asset Advisors LLC Veracyte, Inc. Transaction History

Knights Of Columbus Asset Advisors LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$19.49 - $28.11 $1.02 Million - $1.47 Million	-52,201 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$16.13 - $30.17 $30,082 - $56,267	-1,865 Reduced 3.45%	52,201 $1.27 Million
Q4 2019 Feb 14, 2020	BUY	$20.78 - $29.99 $1.12 Million - $1.62 Million	54,066 New	54,066 $1.51 Million

308

81.8M

134K

13.3K

Ticker VCYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,575,904
Market Cap $3.07B
Description
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...

Get notified when there are updates to the investment portfolio of Knights Of Columbus Asset Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Knights Of Columbus Asset Advisors LLC with notifications on news.